MLMegan Li Xian Lee

Megan Li Xian Lee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Megan Li Xian Lee has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Amaury Cazenave-Gassiot

    Singapore Lipidomics Incubator, Life Sciences Institute, National University of Singapore, Singapore, Singapore

    2 shared publications
  • Federico Torta

    Precision Medicine Translational Research Programme and Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; SLING, Singapore Lipidomics Incubator, Life Sciences Institute, National University of Singapore, Singapore; Signature Research Program in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore Medical School, Singapore

    1 shared publication
  • Jerry Kok Yen Chan

    Duke-National University of Singapore (NUS) Medical School

    1 shared publication
  • Johan G. Eriksson

    Singapore Institute for Clinical Sciences

    1 shared publication
  • Kim Ngan T. Nguyen

    Wilmar Innovation Center

    1 shared publication
  • Untzizu Elejalde

    Wilmar Innovation Center

    1 shared publication

Latest Publications

  • Open Access

    Fatty acid esters of hydroxy fatty acids and alkyl-diacylglycerols: minor but bioactive components in human milk

    by Megan Li Xian Lee, Untzizu Elejalde, Amaury Cazenave-Gassiot

    As the optimal source of nutrition for infants, investigations into the human milk lipidome have been quite extensive. Much of the work, however, has been focused on major lipid components such as triglycerides, possibly undermining its actual complexity. This review focuses on two minor but bioactive lipid classes in human milk: fatty acid esters of hydroxy fatty acids (FAHFAs) and alkyl-diacylglycerols (TG(O)s). FAHFAs are known to exhibit anti-diabetic and anti-inflammatory effects, while TG(O)s are important for the prevention of childhood obesity. With the knowledge that early nutrition and metabolic health influence the risk of metabolic dysfunctions later in life, a comprehensive understanding of FAHFAs and TG(O)s, along with reliable characterisations in human milk, would better allow for the development of accurate human milk fat substitutes. This could have future implications as alternative or preventive treatments for infants with early markers of metabolic dysfunction, including diabetes and obesity. The structural characteristics, pathways for biosynthesis and degradation, bioactivity, dietary sources, and characterisations of FAHFAs and TG(O)s in human milk are discussed. Their statuses as emerging lipid classes, however, is reflected in the incomplete understanding of their biochemical pathways. Characterisations of FAHFAs and TG(O)s in human milk are relatively poor, and contradicting results are reported. This review also addresses the challenges involved in the study of minor lipids in complex biological matrices, and the possible reasons underlying the slower evolution of our understanding of FAHFAs and TG(O)s in human milk and their associations with health outcomes.

  • Measurement of Endogenous Fatty Acid Esters of Hydroxy Fatty Acid (FAHFA) and Alkyl-diacylglycerol (TG(O)) from Human Breast Milk

    by Megan Li Xian Lee, Kim Ngan T. Nguyen, Wei Wei Pang, Federico Torta, Yap Seng Chong, Johan G. Eriksson, Jerry Kok Yen Chan, Untzizu Elejalde, Amaury Cazenave-Gassiot

    Fatty acid esters of hydroxy fatty acids (FAHFAs) and alkyl-diacylglycerols (TG-(O)-s) are endogenous lipids that exert protective effects against diabetes, inflammation, and the development of childhood obesity. They have been identified as minor lipids in human breast milk, and an accurate characterization of FAHFAs and TG-(O)-s could further our understanding of changes in human milk lipid profiles across different phenotypes. However, due to differences in their polarities and chemical properties, current studies on FAHFAs and TG-(O)-s tend to be conducted independently. The study of these compounds is further complicated by a shortage of validated methods for the isolation of FAHFAs and TG-(O)-s from complex, lipid-rich biological matrices, such as human breast milk. Additionally, cohort studies on human tissues, including breast milk, are often confronted with limited sample availability. In this study, we describe the systematic validation of a workflow to reliably extract, isolate, and characterize both FAHFAs and TG-(O)-s from 1.6 mL of human breast milk. We have applied this method to the measurement of 16 and 19 endogenous FAHFA and TG-(O) species originating from two cohort studies, respectively. Our validated workflow also includes the application of liquid chromatography-multistage mass spectrometry approaches to identify FAHFA and TG-(O) molecular species as well as FAHFA regioisomers. This method has the potential to be adapted for the isolation and characterization of other minor lipids with different polarities from limited sample volumes of complex biological matrices.